Brandon A Santhumayor, Timothy G White, Danielle Golub, Moses Rivera, Justin Turpin, David Golombeck, Brendan Ryu, Kevin Shah, Rafael Ortiz, Karen Black, Jeffrey M Katz, Amir R Dehdashti, David J Langer
Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288-299.
Ohkura A, Negoto T, Aoki T, et al. Stenotic changes of the posterior cerebral artery are a major contributing factor for cerebral infarction in moyamoya disease. Surg Neurol Int. 2018;9:105.
Mertens R, Graupera M, Gerhardt H, et al. The genetic basis of moyamoya disease. Transl Stroke Res. 2022;13(1):25-45.
Ihara M, Yamamoto Y, Hattori Y, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21(8):747-758.
Jang DK, Lee KS, Rha HK, et al. Clinical and angiographic features and stroke types in adult moyamoya disease. AJNR Am J Neuroradiol. 2014;35(6):1124-1131.
Lee SU, Oh CW, Kwon OK, et al. Surgical treatment of adult moyamoya disease. Curr Treat Options Neurol. 2018;20(7):22.
Storey A, Michael Scott R, Robertson R, Smith E. Preoperative transdural collateral vessels in moyamoya as radiographic biomarkers of disease. J Neurosurg Pediatr. 2017;19(3):289-295.
Funaki T, Takahashi JC, Yoshida K, et al. Periventricular anastomosis in moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg. 2016;124(6):1766-1772.
Sato Y, Kazumata K, Nakatani E, Houkin K, Kanatani Y. Characteristics of moyamoya disease based on national registry data in Japan. Stroke. 2019;50(8):1973-1980.
Nossek E, Langer DJ. How I do it: combined direct (STA-MCA) and indirect (EDAS) EC-IC bypass. Acta Neurochir (Wien). 2014;156(11):2079-2084.
Zhao M, Amin-Hanjani S, Ruland S, Curcio AP, Ostergren L, Charbel FT. Regional cerebral blood flow using quantitative MR angiography. AJNR Am J Neuroradiol. 2007;28(8):1470-1473.
Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226-1237.
Rankin J. Cerebral vascular accidents in patients over the age of 60: II. Prognosis. Scottish Med J. 1957;2(5):200-215.
Liu ZW, Han C, Wang H, et al. Clinical characteristics and leptomeningeal collateral status in pediatric and adult patients with ischemic moyamoya disease. CNS Neurosci Ther. 2020;26(1):14-20.
Vajkoczy P. Moyamoya disease: collateralization is everything. Cerebrovasc Dis. 2009;28(3):258.
Miyoshi K, Chida K, Kobayashi M, et al. Two-year clinical, cerebral hemodynamic, and cognitive outcomes of adult patients undergoing medication alone for symptomatically ischemic moyamoya disease without cerebral misery perfusion: a prospective cohort study. Neurosurgery. 2019;84(6):1233-1241.
Sato S, Kojima D, Shimada Y, et al. Preoperatively reduced cerebrovascular contractile reactivity to hypocapnia by hyperventilation is associated with cerebral hyperperfusion syndrome after arterial bypass surgery for adult patients with cerebral misery perfusion due to ischemic moyamoya disease. J Cereb Blood Flow Metab. 2018;38(6):1021-1031.
Ohta S, Meyer E, Thompson CJ, Gjedde A. Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen. J Cereb Blood Flow Metab. 1992;12(2):179-192.
Kuroda H, Ogasawara K, Suzuki T, et al. Accuracy of central benzodiazepine receptor binding potential/cerebral blood flow SPECT imaging for detecting misery perfusion in patients with unilateral major cerebral artery occlusive diseases: comparison with cerebrovascular reactivity to acetazolamide and cerebral blood flow SPECT imaging. Clin Nucl Med. 2012;37(3):235-240.
Khan N, Lober RM, Ostergren L, et al. Measuring cerebral blood flow in moyamoya angiopathy by quantitative magnetic resonance angiography noninvasive optimal vessel analysis. Neurosurgery. 2017;81(6):921-927.
White T, Gandhi S, Langer DJ, Katz JM, Dehdashti AR. Does advanced imaging aid in the preoperative evaluation of patients with moyamoya disease? Cureus. 2022;14(10):e29816.
Amin-Hanjani S, Shin JH, Zhao M, Du X, Charbel FT. Evaluation of extracranial–intracranial bypass using quantitative magnetic resonance angiography. J Neurosurg. 2007;106(2):291-298.
Amin-Hanjani S, Singh A, Rifai H, et al. Combined direct and indirect bypass for moyamoya: quantitative assessment of direct bypass flow over time. Neurosurgery. 2013;73(6):962-968; discussion 7-8.
Starke RM, Chwajol M, Lefton D, Sen C, Berenstein A, Langer DJ. Occipital artery-to-posterior inferior cerebellar artery bypass for treatment of bilateral vertebral artery occlusion: the role of quantitative magnetic resonance angiography noninvasive optimal vessel analysis: technical case report. Neurosurgery. 2009;64(4):e779-e781; discussion e81.
Kim T, Bang JS, Kwon OK, et al. Hemodynamic changes after unilateral revascularization for moyamoya disease: serial assessment by quantitative magnetic resonance angiography. Neurosurgery. 2017;81(1):111-119.
Rosi A, Riordan CP, Smith ER, Scott RM, Orbach DB. Clinical status and evolution in moyamoya: which angiographic findings correlate? Brain Commun. 2019;1(1):fcz029.
Amin-Hanjani S, Du X, Mlinarevich N, Meglio G, Zhao M, Charbel FT. The cut flow index: an intraoperative predictor of the success of extracranial-intracranial bypass for occlusive cerebrovascular disease. Neurosurgery. 2005;56(1 Suppl):75-85; discussion 75–85.